317 related articles for article (PubMed ID: 2519901)
1. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
[TBL] [Abstract][Full Text] [Related]
2. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig.
Touvay C; Vilain B; Lejeune V; Mencia-Huerta JM; Braquet P
Biochem Biophys Res Commun; 1989 Aug; 163(1):118-23. PubMed ID: 2775253
[TBL] [Abstract][Full Text] [Related]
4. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397
[TBL] [Abstract][Full Text] [Related]
5. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
Piper PJ; Stewart AG
Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
[TBL] [Abstract][Full Text] [Related]
7. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart.
Viossat I; Chapelat M; Chabrier PE; Braquet P
Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig.
Touvay C; Pfister A; Vilain B; Carré C; Page CP; Lellouch-Tubiana A; Pignol B; Mencia-Huerta JM; Braquet P
Pulm Pharmacol; 1991; 4(1):43-51. PubMed ID: 1804494
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
10. Paf-induced release of spasmogens from guinea-pig lungs.
Jancar S; Thériault P; Lauzière M; Braquet P; Sirois P
Br J Pharmacol; 1989 Jan; 96(1):153-62. PubMed ID: 2538179
[TBL] [Abstract][Full Text] [Related]
11. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
13. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
[TBL] [Abstract][Full Text] [Related]
14. Platelet activating factor antagonists interact with GABAA receptors.
Miller LG; Bazan NG; Roy RB; Clostre F; Gaver A; Braquet P
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):253-6. PubMed ID: 1667341
[TBL] [Abstract][Full Text] [Related]
15. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
Ostermann G; Hofmann B; Kertscher HP; Till U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
[TBL] [Abstract][Full Text] [Related]
17. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Harczy M; Maclouf J; Pradelles P; Braquet P; Borgeat P; Sirois P
Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849
[TBL] [Abstract][Full Text] [Related]
19. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs.
Lagente V; Boichot E; Carre C; Guinot P; Mencia-Huerta JM; Braquet P
Clin Exp Allergy; 1993 Dec; 23(12):1002-10. PubMed ID: 10779293
[TBL] [Abstract][Full Text] [Related]
20. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
Pritze S; Simmet T; Peskar BA
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
